Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$23,175,289
+$4,193,415 QoQ
Shares Held
92,097
+5.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#563
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ELEVATION POINT WEALTH PARTNERS, LLC holds $156,714,234 across 14 Drug Manufacturers - General names. ABBV ranks #3 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
42,067 | $50,456,426 | |
| 2 | JNJ |
Johnson & Johnson
|
94,695 | $24,049,689 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
92,097 | $23,175,289 | |
| 4 | MRK |
Merck & Co., Inc.
|
145,564 | $18,704,974 | |
| 5 | AMGN |
Amgen Inc
|
25,505 | $9,235,870 | |
| 6 | PFE |
Pfizer Inc
|
316,786 | $7,628,206 | |
| 7 | NVS |
Novartis AG
|
47,580 | $7,456,737 | |
| 8 | AZN |
Astrazeneca PLC
|
38,745 | $7,346,826 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,175,289 | 92,097 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $18,981,874 | 87,277 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $7,737,356 | 33,863 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $7,588,491 | 32,774 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,477,525 | 24,122 | Shares | Sole | 2026-02-03 | |
| 2025-03-31 | $5,672,544 | 27,074 | Shares | Sole | 2026-02-03 | |
| 2024-12-31 | $5,073,690 | 28,552 | Shares | Sole | 2026-02-03 | |
| 2024-09-30 | $5,339,464 | 27,038 | Shares | Sole | 2026-02-03 | |
| 2024-06-30 | $4,840,808 | 28,223 | Shares | Sole | 2026-02-03 | |
| 2024-03-31 | $4,278,621 | 23,496 | Shares | Sole | 2026-02-03 | |
| 2023-12-31 | $3,549,897 | 22,907 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,459,682 | 23,210 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $2,820,168 | 20,932 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,739,935 | 23,467 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,909,830 | 24,193 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,308,947 | 24,655 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $5,130,400 | 33,497 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $5,283,975 | 32,595 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $4,435,839 | 32,761 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $3,558,415 | 32,988 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $3,565,731 | 31,656 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $3,335,989 | 30,826 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $3,318,006 | 30,966 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,507,176 | 28,624 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,091,491 | 31,488 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $2,038,082 | 26,750 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||